Managing Partner
and access,
Luke is a Managing Partner of O2 Investment Partners and a member of the Firm’s Investment Committee. He has over 20 years of M&A, investment banking and operational management team experience. He is responsible for evaluating, structuring, negotiating and financing transactions, as well as monitoring O2’s portfolio companies and leading the execution of the deal team. Luke is a former Director of Strategic Planning for Hanford Pharmaceuticals, Senior Associate at Square 1 Bank and Analyst at Wells Fargo Securities (Healthcare Investment Banking Group). His experiences include leading companies through divestiture plans during the recession, publicly traded and private company deal facilitation for M&A, debt and equity transactions, and managing the build-out of a boutique venture debt bank. Luke serves on the Boards of O2’s portfolio businesses: Modular Devices, Capital Construction, Flip Electronics, First Class Air Holdings and Frontier Dental Super Holdings. Luke received his BA in Economics from Harvard University, where he graduated with honors. While attending Harvard, Luke also studied Corporate Accounting at MIT’s Sloan Business School.
Hanford Pharmaceuticals LLC
Wachovia Corporation
Hanford Pharmaceuticals LLC
Wachovia Securities